Thursday, April 30, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Uncertainty & Complexity

Empathy Gaps, Moral Hazards

Daily Remedy by Daily Remedy
August 27, 2022
in Uncertainty & Complexity
0
Empathy Gaps, Moral Hazards

We have many successful physicians. But we have few who do right by their patients. The dichotomy is jarring.

It appears because healthcare suffers from moral hazards. The perverse incentives are everywhere. We pretend to ignore them. So instead of moral hazards, we say moral injury, or find some clever catchphrase to belie the truth. We claim physicians are suffering because they are overworked. But physicians have been working fewer hours decade over decade since the 1970s – though the relative time a physician spends on non-clinical tasks is increasing.

So, to be a great physician today, you must prioritize the system of healthcare over the individual patient. This is the dichotomy.

A decade ago, a successful physician saw as many patients as possible throughout the day, but spent hardly any time with any one patient. Today, a successful physician is one who best documents the patient encounter, jotting every phrase or code necessary to maximize the financial reimbursement. As a result, physicians went from treating patients bedside to essaying the most elaborate patient notes.

These are the symptoms of a system rife with moral hazards. We see it throughout healthcare. For any proposed solution, we find an ulterior motive. These are the on-ground realities of a healthcare system laced with questionable incentives. When hospitals began incurring penalties for readmissions, hospital leaders began changing the readmitting diagnoses.

No proposed solution, whether it is to improve outcomes or reduce costs, can work until we fix the moral hazard problem. It emerged when we transformed clinical medicine into a healthcare system. Out of that complexity formed a matrix of incentives. None of which are alone wrong, but when combined, produce recurring patterns of moral hazards.

Leaders in healthcare no longer respond to the intended effect of any policy. They react to the implicit moral hazards within it. While we may never find an exact solution, we can at least begin to address the matter with effective leadership.

Right now, these leaders lack the ability to guide because they have lost touch with the individual patient. We put too many degrees of separation between patients and health leaders.

The moral hazards appear within the separation. It explains why healthcare leaders prioritize reducing length of stay with little regard to the individual patient experience; why patients discharged with congestive heart failure suddenly get readmitted with acute respiratory distress. The leaders never see the patient; they only see the data points, and by proxy, the financials.

Data never convey empathy, so health leaders remain blind to it. They never see how financial decisions affect the patient experience. This underlies the network of moral hazards.

When we separate cause and effect, people lose sight of the consequences of their actions. Clinical decisions are not burdened by the weight of the outcomes. And without such anchoring, we lose sight of why we care for patients.

The solution, or at least the start to it, is not difficult: Fill the empathy gap by connecting cause and effect. Ensure patients and healthcare leaders interact over more than data-driven cash flow statements. A leader who sees the faces of patients affected by his or her policy will make decisions quite differently from someone who only sees the metrics.

Empathy is funny like that. We never notice it until it is long gone. Only then does it become apparent by what appears in its absence. As healthcare grew, it became more complicated. Eventually, it grew beyond the comprehension of any one person. This is when medicine became a healthcare system: a necessary change to accommodate the growing patient population and the influx of technology into medical care.

But now the system has grown beyond recognition. The incentives designed to make healthcare more efficient have created undue separations, disconnecting parts that were never meant to be split.

Within these crevices emerged the moral hazards, creating empathy gaps to fill the void.

It is time we acknowledge them in healthcare. So we may study the effects of empathy on patient care. Hopefully, we learn that it is more than an emotion derived from experience; it is the essence of good clinical care.

ShareTweet
Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

An in-depth exploration of drug pricing, including key databases like NADAC, WAC, and ASP, and how they influence the pharmaceutical supply chain, policy, and patient advocacy. The episode also introduces MedPricer's innovative pricing intelligence platform, offering valuable insights for healthcare professionals, policymakers, and patients.

Chapters

00:00 Understanding Drug Pricing Dynamics
03:52 Exploring the Drug Pricing Database
10:07 Patient Advocacy and Drug Pricing
13:56 Market Intelligence in Drug Pricing
How NADAC, WAC, and ASP Shape Drug CostsDaily Remedy
YouTube Video X-Tfwy7XKEg
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

by Daily Remedy
April 19, 2026
0

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • Employer-Sponsored Insurance Is Breaking Down. Price Data Tells You Where It’s Happening First.

    Employer-Sponsored Insurance Is Breaking Down. Price Data Tells You Where It’s Happening First.

    0 shares
    Share 0 Tweet 0
  • Drug Pricing Transparency in an Era of Political Polarization: What MedPricer’s Data Reveals About a Contested Policy Landscape

    0 shares
    Share 0 Tweet 0
  • The Importance of Access Control in the Workplace

    0 shares
    Share 0 Tweet 0
  • Chronic Care Toolbox

    1 shares
    Share 0 Tweet 0
  • State Regulators and the Federal Data Gap: How MedPricer Fills What CMS Leaves Incomplete

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy